Foundation year: 2005

NACE classifier: Farmaceitisko pamatvielu ražošana; Tehniskā pārbaude un analīze

Valid certificates:

GMP

Turnover in the last 5 years

Millions EUR

Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2016 to 2020.

Number of employees in total and after education in the last 5 years

People

Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2016 to 2020.

PHARMIDEA is a pharmaceutical manufacturer of generic drugs. The core competence is manufacturing small batch size sterile products in vials - lyophilized and liquid forms.

Company services include: contract manufacturing, technology development, validation, elaboration of specifications and test methods, stability studies, documentation development for product registration, Out-licensing and serialization.

Export volume over the last 5 years

Millions EUR

Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2016 to 2020.

Main markets

  1. 1. Czech Republic
  2. 2. France
  3. 3. Israel
  4. 4. Russia
  5. 5. Turkey
  6. 6. Ukraine
  7. 7. Germany
  8. 8. Vietnam
  9. 9. Sweden

Target Markets

  1. 1. United Arab Emirates
  2. 2. Australia
  3. 3. Belarus
  4. 4. Egypt
  5. 5. Jordan
  6. 6. Kazakhstan
  7. 7. Kuwait
  8. 8. China
  9. 9. Lebanon
  10. 10. Malaysia
  11. 11. Morocco
  12. 12. Saudi Arabia
  13. 13. Tunisia
  14. 14. Ukraine

In which areas are looking for cooperation

  • Manufacturing of active pharmaceutical ingredients and pharmaceuticals

Investing in R&D

Millions EUR

Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2016 to 2020.

Products

Atosiban

Atosiban 6.75mg/0.9ml solution for injection Atosiban 37.5mg/5ml concentrate for solution for infusion Atosiban is an inhibitor of the hormones oxytocin and vasopressin and indicated to delay imminent preterm birth for women with a gestational age from 24 until 33 completed weeks.

Carbetocin

Carbetocin 100 micrograms/ml solution for injection Carbetocin is a long-acting synthetic Oxytocin analogue indicated for the prevention of uterine atony following delivery of the infant by caesarean section.
Dexmedetomidine 100 µg/ml concentrate for solution for infusion Dexmedetomidine is a highly selective α2-adrenergic agonist indicated for light to moderate sedation in an intensive care setting without the risk of respiratory depression.

Foundation year: 2005

NACE classifier: Farmaceitisko pamatvielu ražošana; Tehniskā pārbaude un analīze

Turnover in the last 5 years

Millions EUR

Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2016 to 2020.

2016 2017 2018 2019 2020
3586723 5491489 5298638 7959371 n/a

Number of employees in total and after education in the last 5 years

People

Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2016 to 2020.

2016 2017 2018 2019 2020
With higher education 30 39 44 50 53
With secondary and professional education 18 24 33 34 42
Number of employees in total 48 63 77 84 95

In which areas are looking for cooperation

  • Manufacturing of active pharmaceutical ingredients and pharmaceuticals

Export volume over the last 5 years

Millions EUR

Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2016 to 2020.

2016 2017 2018 2019 2020
3426645 5360099 5033706.1 7768315 n/a

Main markets

  1. 1. Czech Republic
  2. 2. France
  3. 3. Israel
  4. 4. Russia
  5. 5. Turkey

Target Markets

  1. 1. United Arab Emirates
  2. 2. Australia
  3. 3. Belarus
  4. 4. Egypt
  5. 5. Jordan
  6. 6. Kazakhstan
  7. 7. Kuwait
  8. 8. China
  9. 9. Lebanon
  10. 10. Malaysia
  11. 11. Morocco
  12. 12. Saudi Arabia
  13. 13. Tunisia
  14. 14. Ukraine

Investing in R&D

Millions EUR

Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2016 to 2020.

2016 2017 2018 2019 2020
n/a 884648 929577 1113157 n/a

PHARMIDEA SIA 

Description about enterprise:

PHARMIDEA is a pharmaceutical manufacturer of generic drugs. The core competence is manufacturing small batch size sterile products in vials - lyophilized and liquid forms.

Company services include: contract manufacturing, technology development, validation, elaboration of specifications and test methods, stability studies, documentation development for product registration, Out-licensing and serialization.

Valid certificates:

GMP

Products

Atosiban

Atosiban 6.75mg/0.9ml solution for injection Atosiban 37.5mg/5ml concentrate for solution for infusion Atosiban is an inhibitor of the hormones oxytocin and vasopressin and indicated to delay imminent preterm birth for women with a gestational age from 24 until 33 completed weeks.

Carbetocin

Carbetocin 100 micrograms/ml solution for injection Carbetocin is a long-acting synthetic Oxytocin analogue indicated for the prevention of uterine atony following delivery of the infant by caesarean section.
Dexmedetomidine 100 µg/ml concentrate for solution for infusion Dexmedetomidine is a highly selective α2-adrenergic agonist indicated for light to moderate sedation in an intensive care setting without the risk of respiratory depression.